News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tikvah Therapeutics Names Nathan Andrew Shapira, M.D., Ph.D. Executive Director of Clinical Research and Development and Deputy Chief Medical Officer


8/2/2007 9:37:45 AM

ATLANTA, Aug. 2, 2007 (PRIME NEWSWIRE) -- Tikvah Therapeutics, Inc., a biopharmaceutical company focused on new treatment options to better manage central nervous system diseases, announced today the appointment of Nathan Andrew Shapira, M.D., Ph.D. as Executive Director of Clinical Research and Development and Deputy Chief Medical Officer. Dr. Shapira will help to lead teams of researchers in the design, development, and execution of clinical development programs for Tikvah Therapeutics' neurological and psychiatric pharmaceutical products.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES